A new era of treating neurological diseases at the blood-brain-immune interface
A group of scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.
A group of scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.
Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.
Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Scientists have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to new, effective therapies for people with some autoimm…
A major international study has found gout is a chronic illness where genetics is a major cause, rather than lifestyle choices of the sufferer.
Distinct immune ‘signatures’ in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side effects, suggests a new study.
Researchers have developed a new method to recreate a robust and functional human immune system in mice using mononuclear cells from the cord blood. This new kind of mice, that count with most of the human immune cell types with lower host-versus-graft…
Scientists discover how innate immunity envelops bacteria. The protein GBP1 is a vital component of our body’s natural defense against pathogens. This substance fights against bacteria and parasites by enveloping them in a protein coat, but how the sub…
Analyzing the genetics of patients that responded well to checkpoint blockade revealed mutations in the gene Asxl1 in immune T cells. Disrupting the Asxl1 gene in T cells enhanced response to immune checkpoint blockade and improved long-term tumor cont…